KETAMINE HYDROCHLORIDE

KETAMINE HYDROCHLORIDE was reported 5132 times

These side effects are most commonly reported by patients taking KETAMINE HYDROCHLORIDE:

# Side effect Count
0 INFUSION SITE PAIN 797
1 DRUG INEFFECTIVE 564
2 NAUSEA 545
3 OFF LABEL USE 539
4 INFUSION SITE ERYTHEMA 501
5 INFUSION SITE SWELLING 347
6 HEADACHE 342
7 DIARRHOEA 317
8 DRUG ABUSE 315
9 DYSPNOEA 313
10 HYPERHIDROSIS 238
11 FATIGUE 237
12 SEDATION 232
13 INFUSION SITE HAEMORRHAGE 227
14 VOMITING 225
15 NIGHTMARE 217
16 HYPOTENSION 212
17 PRODUCT USE IN UNAPPROVED INDICATION 211
18 PAIN 206
19 NEPHROLITHIASIS 194
20 DIZZINESS 185
21 INFUSION SITE INFECTION 151
22 INFUSION SITE DISCHARGE 150
23 THERAPY NON-RESPONDER 150
24 DEVICE DISLOCATION 137
25 DEVICE ISSUE 137
26 DEVICE INFUSION ISSUE 134
27 PAIN IN EXTREMITY 132
28 CONDITION AGGRAVATED 119
29 WEIGHT DECREASED 118
30 INFUSION SITE REACTION 116
31 TOXICITY TO VARIOUS AGENTS 114
32 DEVICE OCCLUSION 113
33 HYDRONEPHROSIS 113
34 INFUSION SITE INDURATION 113
35 MALAISE 110
36 INFUSION SITE PRURITUS 109
37 DEVICE FAILURE 105
38 ANAPHYLACTIC SHOCK 102
39 DECREASED APPETITE 102
40 OXYGEN SATURATION DECREASED 102
41 INFUSION SITE IRRITATION 100
42 DEVICE MAINTENANCE ISSUE 98
43 DERMATITIS CONTACT 97
44 RASH 97
45 DEATH 93
46 PAIN IN JAW 93
47 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 92
48 ASTHENIA 91
49 RESPIRATORY FAILURE 91
50 DEVICE USE ERROR 90
51 PYREXIA 90
52 CYSTITIS 89
53 DEVICE LEAKAGE 88
54 BACK PAIN 87
55 INFUSION SITE WARMTH 86
56 FEELING ABNORMAL 85
57 ANXIETY 84
58 DRUG INTERACTION 84
59 COUGH 83
60 PNEUMONIA 82
61 DEVICE MALFUNCTION 81
62 SOMNOLENCE 81
63 ARTHRALGIA 80
64 TACHYCARDIA 76
65 ABDOMINAL PAIN 72
66 CARDIAC ARREST 72
67 INSOMNIA 72
68 FALL 71
69 ACUTE KIDNEY INJURY 70
70 DRUG HYPERSENSITIVITY 70
71 ABDOMINAL DISTENSION 69
72 DEVICE POWER SOURCE ISSUE 69
73 CHEST PAIN 68
74 DEVICE WIRELESS COMMUNICATION ISSUE 68
75 EPISTAXIS 67
76 ILLNESS 67
77 OVERDOSE 67
78 INSPIRATORY CAPACITY DECREASED 66
79 PERIPHERAL SWELLING 65
80 PURULENT DISCHARGE 64
81 BILIARY TRACT DISORDER 63
82 DEVICE DIFFICULT TO USE 63
83 DYSPNOEA EXERTIONAL 63
84 HYPOXIA 62
85 INFUSION SITE NODULE 62
86 FLUSHING 61
87 PRODUCT USE ISSUE 61
88 URTICARIA 59
89 WEIGHT INCREASED 59
90 CONFUSIONAL STATE 58
91 FLUID RETENTION 58
92 CONSTIPATION 57
93 OEDEMA PERIPHERAL 57
94 ANAPHYLACTIC REACTION 56
95 ERYTHEMA 56
96 HAEMATURIA 56
97 INFUSION SITE DISCOLOURATION 56
98 METABOLIC ACIDOSIS 56
99 MIGRAINE 56
100 SHOCK 55
101 ABDOMINAL PAIN UPPER 54
102 LOSS OF CONSCIOUSNESS 54
103 PRURITUS 54
104 SEPSIS 54
105 DELIRIUM 53
106 INFLUENZA 52
107 HYPERSENSITIVITY 50
108 PRODUCT DOSE OMISSION ISSUE 50
109 PULMONARY HYPERTENSION 50
110 BLADDER DISORDER 49
111 CARDIO-RESPIRATORY ARREST 49
112 INFUSION SITE BRUISING 49
113 INFUSION SITE INFLAMMATION 49
114 PALPITATIONS 49
115 THERAPY PARTIAL RESPONDER 49
116 COVID-19 48
117 DRUG DEPENDENCE 48
118 LIVER FUNCTION TEST ABNORMAL 48
119 MYALGIA 48
120 NASOPHARYNGITIS 48
121 HEPATOTOXICITY 46
122 INCORRECT DOSE ADMINISTERED 46
123 UNINTENTIONAL MEDICAL DEVICE REMOVAL 46
124 ARRHYTHMIA 45
125 HALLUCINATION 45
126 URINARY TRACT DISORDER 45
127 DEVICE PHYSICAL PROPERTY ISSUE 44
128 HEART RATE INCREASED 44
129 HYPERTENSION 44
130 INFUSION SITE DISCOMFORT 44
131 DEVICE ALARM ISSUE 43
132 OEDEMA 43
133 PULMONARY ARTERIAL HYPERTENSION 43
134 DILATATION INTRAHEPATIC DUCT ACQUIRED 42
135 ALANINE AMINOTRANSFERASE INCREASED 41
136 BLOOD PRESSURE INCREASED 41
137 INJECTION SITE PAIN 41
138 STATUS EPILEPTICUS 41
139 BLOOD CREATINE PHOSPHOKINASE INCREASED 40
140 PRODUCT ADMINISTRATION INTERRUPTED 40
141 PULMONARY OEDEMA 40
142 TREMOR 40
143 ABDOMINAL DISCOMFORT 39
144 BLOOD PRESSURE DECREASED 39
145 ELECTROCARDIOGRAM QT PROLONGED 39
146 INFUSION SITE RASH 39
147 BRADYCARDIA 38
148 COMPLETED SUICIDE 37
149 POLLAKIURIA 37
150 VENOOCCLUSIVE LIVER DISEASE 37
151 HAEMORRHAGE 36
152 ANAEMIA 35
153 CHOLANGITIS SCLEROSING 35
154 INFUSION SITE MASS 35
155 PROPOFOL INFUSION SYNDROME 35
156 BRONCHOSPASM 34
157 DEPRESSION 34
158 DEVICE CONNECTION ISSUE 34
159 DYSURIA 34
160 HAEMOGLOBIN INCREASED 34
161 HYPERVOLAEMIA 34
162 AGITATION 33
163 INFECTION 33
164 MITOCHONDRIAL DNA MUTATION 33
165 RESPIRATORY DEPRESSION 33
166 URINARY TRACT INFECTION 33
167 CHEST DISCOMFORT 32
168 DRUG INTOLERANCE 32
169 GASTROINTESTINAL DISORDER 32
170 PLATELET COUNT DECREASED 32
171 POOR QUALITY SLEEP 32
172 PRODUCT LEAKAGE 32
173 RENAL IMPAIRMENT 32
174 SUICIDAL IDEATION 32
175 BILIARY DILATATION 31
176 GENE MUTATION 31
177 HYPOAESTHESIA 31
178 SEASONAL ALLERGY 31
179 CHILLS 30
180 DYSPEPSIA 30
181 INTENTIONAL PRODUCT MISUSE 30
182 INTESTINAL ISCHAEMIA 30
183 PLEURAL EFFUSION 30
184 NASAL CONGESTION 29
185 PARTIAL SEIZURES 29
186 SYNCOPE 29
187 REDUCED BLADDER CAPACITY 28
188 BLOOD GASES ABNORMAL 27
189 CARDIAC FAILURE 27
190 CYSTITIS INTERSTITIAL 27
191 DEPRESSED LEVEL OF CONSCIOUSNESS 27
192 INFUSION SITE CELLULITIS 27
193 SEIZURE 27
194 BLOOD LACTIC ACID INCREASED 26
195 CATARACT 26
196 CYSTITIS ULCERATIVE 26
197 DEVICE ADHESION ISSUE 26
198 DEVICE INFORMATION OUTPUT ISSUE 26
199 ENCEPHALITIS 26
200 LETHARGY 26
201 MUSCLE SPASMS 26
202 PRODUCT USED FOR UNKNOWN INDICATION 26
203 RHABDOMYOLYSIS 26
204 ACUTE RESPIRATORY FAILURE 25
205 CHOLESTASIS 25
206 DEHYDRATION 25
207 LOWER URINARY TRACT SYMPTOMS 25
208 MULTIPLE-DRUG RESISTANCE 25
209 PNEUMOTHORAX 25
210 SWELLING 25
211 CONTRACTED BLADDER 24
212 DEVICE PLACEMENT ISSUE 24
213 DIZZINESS POSTURAL 24
214 PARAESTHESIA 24
215 HYPERKALAEMIA 23
216 INFUSION SITE INJURY 23
217 NECK PAIN 23
218 NEURALGIA 23
219 URINARY INCONTINENCE 23
220 BLOOD ALKALINE PHOSPHATASE INCREASED 22
221 BONE PAIN 22
222 FEBRILE NEUTROPENIA 22
223 FLATULENCE 22
224 GASTROINTESTINAL HAEMORRHAGE 22
225 HALLUCINATION, VISUAL 22
226 HEPATIC FUNCTION ABNORMAL 22
227 MICTURITION URGENCY 22
228 MUSCULAR WEAKNESS 22
229 PRODUCT SUBSTITUTION ISSUE 22
230 RESPIRATORY ARREST 22
231 SEPTIC SHOCK 22
232 URINARY RETENTION 22
233 ANTINUCLEAR ANTIBODY POSITIVE 21
234 APNOEA 21
235 CSF OLIGOCLONAL BAND PRESENT 21
236 HOSPITALISATION 21
237 INJURY 21
238 PLEOCYTOSIS 21
239 URETERIC STENOSIS 21
240 WHITE BLOOD CELL COUNT DECREASED 21
241 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 21
242 CARDIAC DISORDER 20
243 COGNITIVE DISORDER 20
244 CONTUSION 20
245 FACE OEDEMA 20
246 HYPOVOLAEMIA 20
247 INFLUENZA LIKE ILLNESS 20
248 LIVER DISORDER 20
249 SUICIDE ATTEMPT 20
250 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 20
251 TREATMENT FAILURE 20
252 UNRESPONSIVE TO STIMULI 20
253 VISUAL IMPAIRMENT 20
254 ACCIDENTAL OVERDOSE 19
255 ASPARTATE AMINOTRANSFERASE INCREASED 19
256 BLOOD BILIRUBIN INCREASED 19
257 GAIT DISTURBANCE 19
258 GASTROOESOPHAGEAL REFLUX DISEASE 19
259 GENERALISED TONIC-CLONIC SEIZURE 19
260 IMPAIRED WORK ABILITY 19
261 INTRA-ABDOMINAL PRESSURE INCREASED 19
262 MANIA 19
263 MEMORY IMPAIRMENT 19
264 MULTIPLE ORGAN DYSFUNCTION SYNDROME 19
265 NECROSIS ISCHAEMIC 19
266 PERICARDIAL EFFUSION 19
267 SHOCK HAEMORRHAGIC 19
268 STAPHYLOCOCCAL INFECTION 19
269 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 19
270 TOXIC EPIDERMAL NECROLYSIS 19
271 ABSCESS 18
272 ACCIDENTAL DEATH 18
273 BLOOD CREATININE INCREASED 18
274 BRAIN INJURY 18
275 CARDIOMEGALY 18
276 CATHETER SITE ERYTHEMA 18
277 CIRCULATORY COLLAPSE 18
278 DISORIENTATION 18
279 HYPONATRAEMIA 18
280 IMPAIRED QUALITY OF LIFE 18
281 INTENTIONAL MEDICAL DEVICE REMOVAL BY PATIENT 18
282 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 18
283 NEUROPATHY PERIPHERAL 18
284 OXYGEN CONSUMPTION INCREASED 18
285 PANCREATITIS 18
286 PNEUMONIA ASPIRATION 18
287 RHINORRHOEA 18
288 STRESS 18
289 URETERIC OBSTRUCTION 18
290 VASCULAR DEVICE INFECTION 18
291 ANAL INCONTINENCE 17
292 ATRIAL FIBRILLATION 17
293 DEVICE KINK 17
294 DRUG EFFECT LESS THAN EXPECTED 17
295 DRUG WITHDRAWAL SYNDROME 17
296 FEELING HOT 17
297 GENERAL PHYSICAL HEALTH DETERIORATION 17
298 INCORRECT DRUG ADMINISTRATION RATE 17
299 INFUSION SITE VESICLES 17
300 LARYNGOSPASM 17
301 MATERNAL EXPOSURE DURING PREGNANCY 17
302 MENTAL STATUS CHANGES 17
303 PNEUMATOSIS 17
304 PULMONARY EMBOLISM 17
305 RENAL FAILURE 17
306 VISION BLURRED 17
307 ABORTION INDUCED 16
308 ASCITES 16
309 BRAIN FOG 16
310 CELLULITIS 16
311 DRUG ABUSER 16
312 DRUG SCREEN POSITIVE 16
313 DRUG TOXICITY 16
314 EMPHYSEMA 16
315 EXPOSURE DURING PREGNANCY 16
316 HERPES ZOSTER 16
317 URGE INCONTINENCE 16
318 ADVERSE REACTION 15
319 ANGIOPATHY 15
320 BLOOD GLUCOSE INCREASED 15
321 CEREBROVASCULAR ACCIDENT 15
322 COMA 15
323 HAEMOGLOBIN DECREASED 15
324 HAEMOPTYSIS 15
325 HAEMOTHORAX 15
326 HYPERAESTHESIA 15
327 MECHANICAL VENTILATION COMPLICATION 15
328 NERVOUS SYSTEM DISORDER 15
329 NEUROTOXICITY 15
330 PATIENT DISSATISFACTION WITH DEVICE 15
331 PRODUCT MONITORING ERROR 15
332 PRODUCT QUALITY ISSUE 15
333 PYURIA 15
334 STEVENS-JOHNSON SYNDROME 15
335 SUBSTANCE ABUSE 15
336 TREATMENT NONCOMPLIANCE 15
337 UPPER RESPIRATORY TRACT INFECTION 15
338 AMNESIA 14
339 ARTHRITIS 14
340 BALANCE DISORDER 14
341 CATHETER SITE PAIN 14
342 DEPRESSED MOOD 14
343 HYPERTONIC BLADDER 14
344 INJECTION SITE ERYTHEMA 14
345 LEFT VENTRICULAR HYPERTROPHY 14
346 LUNG DISORDER 14
347 NERVOUSNESS 14
348 PANCYTOPENIA 14
349 PERFORATION 14
350 PRODUCT ADHESION ISSUE 14
351 PSYCHOTIC DISORDER 14
352 RESPIRATORY DISTRESS 14
353 SUBSTANCE USE 14
354 THROMBOSIS 14
355 WOUND INFECTION 14
356 ACCIDENTAL EXPOSURE TO PRODUCT 13
357 BLOOD POTASSIUM DECREASED 13
358 BURNING SENSATION 13
359 CARDIOGENIC SHOCK 13
360 CATHETER SITE HAEMORRHAGE 13
361 DEVICE USE ISSUE 13
362 DIABETES INSIPIDUS 13
363 GASTROENTERITIS VIRAL 13
364 HEAD INJURY 13
365 HEPATIC CIRRHOSIS 13
366 HYPERSOMNIA 13
367 HYPOKALAEMIA 13
368 INTENTIONAL PRODUCT USE ISSUE 13
369 MYOCLONUS 13
370 NEUTROPHIL COUNT DECREASED 13
371 SINUSITIS 13
372 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 13
373 UNDERDOSE 13
374 UNEVALUABLE DEVICE ISSUE 13
375 VENTRICULAR TACHYCARDIA 13
376 BLADDER HYPERTROPHY 12
377 BRONCHITIS 12
378 DISEASE PROGRESSION 12
379 DRUG TITRATION ERROR 12
380 DRUG-INDUCED LIVER INJURY 12
381 HYDROCEPHALUS 12
382 INFUSION SITE ABSCESS 12
383 INFUSION SITE SCAR 12
384 INTESTINAL PERFORATION 12
385 JOINT SWELLING 12
386 LIVER ABSCESS 12
387 LIVER INJURY 12
388 MALIGNANT NEOPLASM PROGRESSION 12
389 NEEDLE ISSUE 12
390 PALLOR 12
391 PRODUCTIVE COUGH 12
392 RIGHT VENTRICULAR FAILURE 12
393 SURGERY 12
394 VASCULAR GRAFT OCCLUSION 12
395 VENOOCCLUSIVE DISEASE 12
396 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 12
397 BIOPSY BLADDER ABNORMAL 11
398 BLOOD UREA INCREASED 11
399 CARDIAC FAILURE CONGESTIVE 11
400 CEREBRAL HAEMORRHAGE FOETAL 11
401 CHOLESTATIC LIVER INJURY 11
402 CHRONIC KIDNEY DISEASE 11
403 DEVICE BREAKAGE 11
404 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 11
405 DYSPHAGIA 11
406 DYSPHORIA 11
407 ENCEPHALOPATHY 11
408 EOSINOPHILIA 11
409 EXTRA DOSE ADMINISTERED 11
410 HEPATIC FAILURE 11
411 HEPATITIS 11
412 ILEUS 11
413 INFUSION SITE OEDEMA 11
414 INJECTION SITE HAEMORRHAGE 11
415 PANIC ATTACK 11
416 RECTAL HAEMORRHAGE 11
417 RESPIRATORY DISORDER 11
418 RESPIRATORY TRACT CONGESTION 11
419 RESTLESS LEGS SYNDROME 11
420 RESTLESSNESS 11
421 RETCHING 11
422 SCHIZENCEPHALY 11
423 SENSITIVE SKIN 11
424 SKIN EXFOLIATION 11
425 SUPRAVENTRICULAR TACHYCARDIA 11
426 SUSPECTED OFF LABEL USE 11
427 URETERAL DISORDER 11
428 VIRAL INFECTION 11
429 AGGRESSION 10
430 BLOOD TEST ABNORMAL 10
431 CATHETER SITE DISCHARGE 10
432 CHOLELITHIASIS 10
433 CRYING 10
434 DELUSION 10
435 DEVICE ELECTRICAL FINDING 10
436 DISSOCIATION 10
437 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 10
438 DRY MOUTH 10
439 EXPOSURE VIA SKIN CONTACT 10
440 HAEMODYNAMIC INSTABILITY 10
441 HYPERTRANSAMINASAEMIA 10
442 HYPOACUSIS 10
443 INFUSION SITE SCAB 10
444 INJECTION SITE BRUISING 10
445 INTENTIONAL OVERDOSE 10
446 MEDICATION ERROR 10
447 MENTAL IMPAIRMENT 10
448 MOBILITY DECREASED 10
449 NEUTROPENIA 10
450 OROPHARYNGEAL PAIN 10
451 PULMONARY HAEMORRHAGE 10
452 PULSELESS ELECTRICAL ACTIVITY 10
453 RENAL FAILURE ACUTE 10
454 ROAD TRAFFIC ACCIDENT 10
455 SALIVARY HYPERSECRETION 10
456 SEROTONIN SYNDROME 10
457 SLEEP DISORDER 10
458 STOMATITIS 10
459 URETERITIS 10
460 URINARY TRACT OBSTRUCTION 10
461 ABNORMAL BEHAVIOUR 9
462 ACIDOSIS 9
463 ADVERSE EVENT 9
464 ALOPECIA 9
465 BACTERAEMIA 9
466 C-REACTIVE PROTEIN INCREASED 9
467 CATHETER SITE SWELLING 9
468 CYANOSIS 9
469 CYTOKINE RELEASE SYNDROME 9
470 DIABETES MELLITUS 9
471 DISSEMINATED INTRAVASCULAR COAGULATION 9
472 DISTRIBUTIVE SHOCK 9
473 DRY SKIN 9
474 DYSGEUSIA 9
475 DYSKINESIA 9
476 ECZEMA 9
477 FOETAL EXPOSURE DURING PREGNANCY 9
478 GENERALISED ERYTHEMA 9
479 HAEMATEMESIS 9
480 HAEMATOCHEZIA 9
481 HALLUCINATION, AUDITORY 9
482 HOT FLUSH 9
483 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 9
484 INJECTION SITE SWELLING 9
485 IRRITABILITY 9
486 LIMB DISCOMFORT 9
487 MIOSIS 9
488 POISONING 9
489 RASH ERYTHEMATOUS 9
490 RASH MACULAR 9
491 RASH MACULO-PAPULAR 9
492 REFUSAL OF TREATMENT BY PATIENT 9
493 RENAL DISORDER 9
494 SKIN DISORDER 9
495 SPEECH DISORDER 9
496 STRESS CARDIOMYOPATHY 9
497 SUSPECTED SUICIDE 9
498 THROMBOCYTOPENIA 9
499 TINNITUS 9
500 URETERAL POLYP 9
501 VENTRICULAR FIBRILLATION 9
502 WITHDRAWAL SYNDROME 9
503 ALTERED STATE OF CONSCIOUSNESS 8
504 ANGIOEDEMA 8
505 BLOOD PRESSURE FLUCTUATION 8
506 COMPLICATION ASSOCIATED WITH DEVICE 8
507 CONVULSION 8
508 DELAYED RECOVERY FROM ANAESTHESIA 8
509 DEVICE DELIVERY SYSTEM ISSUE 8
510 DRUG TOLERANCE 8
511 DRUG TOLERANCE DECREASED 8
512 EPILEPSY 8
513 EUPHORIC MOOD 8
514 EXPIRED PRODUCT ADMINISTERED 8
515 FEEDING DISORDER 8
516 FUNGAL INFECTION 8
517 GAMMA-GLUTAMYLTRANSFERASE INCREASED 8
518 HAEMORRHOIDS 8
519 HEPATOCELLULAR INJURY 8
520 HYDROURETER 8
521 HYPERCAPNIA 8
522 INCREASED BRONCHIAL SECRETION 8
523 INFUSION SITE EXTRAVASATION 8
524 INFUSION SITE STREAKING 8
525 INFUSION SITE URTICARIA 8
526 LIMB INJURY 8
527 MUSCULOSKELETAL STIFFNESS 8
528 POSTOPERATIVE DELIRIUM 8
529 PRESYNCOPE 8
530 PROCEDURAL PAIN 8
531 PSYCHOMOTOR HYPERACTIVITY 8
532 SKIN DISCOLOURATION 8
533 SLEEP APNOEA SYNDROME 8
534 SWELLING FACE 8
535 TRANSAMINASES INCREASED 8
536 VERTIGO 8
537 WEIGHT FLUCTUATION 8
538 ASPHYXIA 7
539 BLOOD PH DECREASED 7
540 BRAIN OEDEMA 7
541 BREAST CANCER 7
542 CATHETER SITE IRRITATION 7
543 CHOLANGITIS 7
544 COVID-19 PNEUMONIA 7
545 CYSTITIS NONINFECTIVE 7
546 DEEP VEIN THROMBOSIS 7
547 DEVICE LOOSENING 7
548 DISEASE RECURRENCE 7
549 DISSOCIATIVE DISORDER 7
550 DYSARTHRIA 7
551 DYSTONIA 7
552 EAR PAIN 7
553 END STAGE RENAL DISEASE 7
554 FEMUR FRACTURE 7
555 FULL BLOOD COUNT DECREASED 7
556 HEAD DISCOMFORT 7
557 HEPATIC ENZYME INCREASED 7
558 HYPERLIPIDAEMIA 7
559 HYPOALBUMINAEMIA 7
560 HYPOPHAGIA 7
561 INFUSION SITE HYPERSENSITIVITY 7
562 INJECTION SITE PRURITUS 7
563 INTESTINAL OBSTRUCTION 7
564 MAJOR DEPRESSION 7
565 MUSCULOSKELETAL CHEST PAIN 7
566 NEW ONSET REFRACTORY STATUS EPILEPTICUS 7
567 NOCTURIA 7
568 PANCREATITIS ACUTE 7
569 POST-TRAUMATIC STRESS DISORDER 7
570 PROTHROMBIN TIME PROLONGED 7
571 PYELONEPHRITIS 7
572 SCHIZOPHRENIA 7
573 SEDATION COMPLICATION 7
574 SKIN LESION 7
575 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 7
576 TARDIVE DYSKINESIA 7
577 THERAPEUTIC RESPONSE DECREASED 7
578 THERAPEUTIC RESPONSE UNEXPECTED 7
579 TRISMUS 7
580 UNEVALUABLE EVENT 7
581 WHITE BLOOD CELL COUNT INCREASED 7
582 ARTERIOSPASM CORONARY 6
583 BLISTER 6
584 BLOOD GLUCOSE DECREASED 6
585 BLOOD IMMUNOGLOBULIN E INCREASED 6
586 BURKHOLDERIA TEST POSITIVE 6
587 CANDIDA INFECTION 6
588 CARDIOMYOPATHY 6
589 CEREBRAL HAEMORRHAGE 6
590 COLON CANCER 6
591 DISCOMFORT 6
592 DISTURBANCE IN ATTENTION 6
593 DRUG MONITORING PROCEDURE INCORRECTLY PERFORMED 6
594 DYSPHONIA 6
595 FIBROMYALGIA 6
596 FINE MOTOR SKILL DYSFUNCTION 6
597 FOLLICULITIS 6
598 FUNCTIONAL GASTROINTESTINAL DISORDER 6
599 GALLBLADDER DISORDER 6
600 GASTRITIS 6
601 GASTROINTESTINAL MOTILITY DISORDER 6
602 GLUCOSE TOLERANCE IMPAIRED 6
603 GRAND MAL CONVULSION 6
604 HEAVY MENSTRUAL BLEEDING 6
605 HEPATIC CYTOLYSIS 6
606 HYPERKINESIA 6
607 HYPERTROPHIC CARDIOMYOPATHY 6
608 HYPOCALCAEMIA 6
609 HYPOPERFUSION 6
610 HYPOVENTILATION 6
611 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 6
612 INFECTION SUSCEPTIBILITY INCREASED 6
613 INFUSION RELATED REACTION 6
614 INFUSION SITE DRYNESS 6
615 INHIBITORY DRUG INTERACTION 6
616 INJECTION SITE DISCHARGE 6
617 INJECTION SITE IRRITATION 6
618 INJECTION SITE REACTION 6
619 JAUNDICE 6
620 JAUNDICE CHOLESTATIC 6
621 LACRIMATION INCREASED 6
622 LACTIC ACIDOSIS 6
623 LARYNGEAL OEDEMA 6
624 LOCALISED INFECTION 6
625 LYMPHADENOPATHY 6
626 LYMPHOCYTE COUNT DECREASED 6
627 METABOLIC SYNDROME 6
628 MUSCLE RIGIDITY 6
629 MYOCARDIAL INFARCTION 6
630 NIGHT SWEATS 6
631 PARANOIA 6
632 PARONYCHIA 6
633 POLYURIA 6
634 POST PROCEDURAL COMPLICATION 6
635 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 6
636 POSTOPERATIVE WOUND INFECTION 6
637 RASH PRURITIC 6
638 RENAL FUNCTION TEST ABNORMAL 6
639 RESPIRATION ABNORMAL 6
640 SECRETION DISCHARGE 6
641 SINUS CONGESTION 6
642 SINUS DISORDER 6
643 SKIN IRRITATION 6
644 SKIN REACTION 6
645 SKIN ULCER 6
646 SUBSTANCE DEPENDENCE 6
647 THERAPEUTIC PRODUCT EFFECT DECREASED 6
648 THROAT IRRITATION 6
649 THROAT TIGHTNESS 6
650 VASCULITIS 6
651 WHEEZING 6
652 ABNORMAL DREAMS 5
653 ADMINISTRATION SITE ODOUR 5
654 ADVERSE DRUG REACTION 5
655 AGRANULOCYTOSIS 5
656 AIRWAY COMPLICATION OF ANAESTHESIA 5
657 APPENDICITIS 5
658 ASPIRATION 5
659 BLADDER DYSFUNCTION 5
660 BLOOD SODIUM INCREASED 5
661 BODY TINEA 5
662 BONE DENSITY DECREASED 5
663 BRAIN DEATH 5
664 CAESAREAN SECTION 5
665 CARPAL TUNNEL SYNDROME 5
666 CATATONIA 5
667 CATHETER SITE INFECTION 5
668 CLOSTRIDIUM DIFFICILE INFECTION 5
669 COAGULOPATHY 5
670 CROHN^S DISEASE 5
671 CYSTITIS HAEMORRHAGIC 5
672 CYTOKINE STORM 5
673 DEAFNESS 5
674 DECREASED ACTIVITY 5
675 DEVICE RELATED INFECTION 5
676 DRUG ERUPTION 5
677 DRUG LEVEL DECREASED 5
678 DRUG RESISTANCE 5
679 DRUG TOLERANCE INCREASED 5
680 DRUG USE DISORDER 5
681 DYSSTASIA 5
682 ERUCTATION 5
683 EYE PAIN 5
684 EYELID OEDEMA 5
685 FEAR 5
686 FEELING COLD 5
687 GAIT INABILITY 5
688 GENERALISED OEDEMA 5
689 GINGIVAL BLEEDING 5
690 HAEMATOMA 5
691 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 5
692 HEART RATE DECREASED 5
693 HYPERTHERMIA MALIGNANT 5
694 HYPERTONIA 5
695 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 5
696 IMPULSIVE BEHAVIOUR 5
697 INCOHERENT 5
698 INJECTION SITE INFECTION 5
699 INTERSTITIAL LUNG DISEASE 5
700 IRRITABLE BOWEL SYNDROME 5
701 JOINT EFFUSION 5
702 JOINT INJURY 5
703 LIVER FUNCTION TEST INCREASED 5
704 LIVER TRANSPLANT 5
705 LUNG NEOPLASM MALIGNANT 5
706 LYMPHOCYTOSIS 5
707 MOUTH HAEMORRHAGE 5
708 MUSCLE TIGHTNESS 5
709 NEOPLASM MALIGNANT 5
710 NYSTAGMUS 5
711 ORAL HERPES 5
712 OXYGEN SATURATION ABNORMAL 5
713 PRE-EXISTING CONDITION IMPROVED 5
714 PRODUCT COMMUNICATION ISSUE 5
715 PRODUCT DISPENSING ERROR 5
716 PRODUCT DOSE OMISSION IN ERROR 5
717 PRODUCT PRESCRIBING ERROR 5
718 PURPURA 5
719 RESPIRATORY RATE DECREASED 5
720 SINUS BRADYCARDIA 5
721 SINUS TACHYCARDIA 5
722 SKIN ABRASION 5
723 SNEEZING 5
724 SPINAL PAIN 5
725 STERILE PYURIA 5
726 SYSTEMIC LUPUS ERYTHEMATOSUS 5
727 TASTE DISORDER 5
728 THERAPEUTIC RESPONSE SHORTENED 5
729 UROGENITAL FISTULA 5
730 UROSEPSIS 5
731 WOUND 5
732 WRONG PRODUCT ADMINISTERED 5
733 ABNORMAL SENSATION IN EYE 4
734 ACCIDENT 4
735 ACNE 4
736 ACTIVITIES OF DAILY LIVING IMPAIRED 4
737 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 4
738 ACUTE RESPIRATORY DISTRESS SYNDROME 4
739 AKATHISIA 4
740 ANAESTHETIC COMPLICATION 4
741 ANTITHROMBIN III DECREASED 4
742 APATHY 4
743 APHASIA 4
744 APLASTIC ANAEMIA 4
745 AUTOIMMUNE HEPATITIS 4
746 AUTONOMIC NERVOUS SYSTEM IMBALANCE 4
747 BACTERIAL INFECTION 4
748 BLADDER NECK OBSTRUCTION 4
749 BLOOD BLISTER 4
750 BLOOD CHOLESTEROL INCREASED 4
751 BLOOD LACTATE DEHYDROGENASE INCREASED 4
752 BLOOD PRESSURE ABNORMAL 4
753 BLOOD PRESSURE SYSTOLIC DECREASED 4
754 BLOOD SODIUM DECREASED 4
755 BLOOD URINE PRESENT 4
756 BRADYPNOEA 4
757 BRAIN NATRIURETIC PEPTIDE INCREASED 4
758 BRUGADA SYNDROME 4
759 CANCER PAIN 4
760 CATHETER SITE BRUISE 4
761 CATHETER SITE INDURATION 4
762 CHOLECYSTITIS 4
763 DECUBITUS ULCER 4
764 DEPENDENCE 4
765 DEREALISATION 4
766 DEVICE RELATED SEPSIS 4
767 DEVICE TEMPERATURE ISSUE 4
768 DEVICE USE CONFUSION 4
769 DIET NONCOMPLIANCE 4
770 DIPLOPIA 4
771 DRUG EXPOSURE DURING PREGNANCY 4
772 DYSPNOEA AT REST 4
773 ENDOTRACHEAL INTUBATION 4
774 ENVIRONMENTAL EXPOSURE 4
775 ERYTHEMA OF EYELID 4
776 EXERCISE TOLERANCE DECREASED 4
777 EYE SWELLING 4
778 FAECES SOFT 4
779 FEELING JITTERY 4
780 FOETAL GROWTH RESTRICTION 4
781 GINGIVAL PAIN 4
782 GOUT 4
783 HAEMATOLOGICAL INFECTION 4
784 HAEMOGLOBIN ABNORMAL 4
785 HEART RATE IRREGULAR 4
786 HEPATIC STEATOSIS 4
787 HEPATITIS CHOLESTATIC 4
788 HEPATOMEGALY 4
789 HIP FRACTURE 4
790 HYPERBILIRUBINAEMIA 4
791 HYPERGLYCAEMIA 4
792 HYPERPHOSPHATAEMIA 4
793 HYPERTHERMIA 4
794 HYPOTONIA 4
795 IMPAIRED GASTRIC EMPTYING 4
796 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 4
797 INFLAMMATION 4
798 INFUSION SITE EROSION 4
799 INFUSION SITE HAEMATOMA 4
800 INJECTION SITE RASH 4
801 INTERNATIONAL NORMALISED RATIO INCREASED 4
802 LABORATORY TEST ABNORMAL 4
803 LARGE INTESTINE PERFORATION 4
804 LEFT VENTRICULAR FAILURE 4
805 LEUKOCYTOSIS 4
806 LEUKOENCEPHALOPATHY 4
807 LOCALISED OEDEMA 4
808 MATERNAL DRUGS AFFECTING FOETUS 4
809 MEDICAL DEVICE SITE PAIN 4
810 MENSTRUATION IRREGULAR 4
811 METAPLASIA 4
812 METHAEMOGLOBINAEMIA 4
813 MONOPLEGIA 4
814 MULTI-ORGAN FAILURE 4
815 MUSCLE ATROPHY 4
816 MYDRIASIS 4
817 MYOCARDIAL DEPRESSION 4
818 NASAL DISCOMFORT 4
819 NEOPLASM PROGRESSION 4
820 OBESITY 4
821 OBSTRUCTIVE NEPHROPATHY 4
822 OCULAR HYPERAEMIA 4
823 PARALYSIS 4
824 PERSONAL RELATIONSHIP ISSUE 4
825 PHARYNGITIS 4
826 POISONING DELIBERATE 4
827 PORPHYRIA ACUTE 4
828 POST PROCEDURAL HAEMORRHAGE 4
829 PRESCRIBED OVERDOSE 4
830 PROCEDURAL INTESTINAL PERFORATION 4
831 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 4
832 PRODUCT PREPARATION ISSUE 4
833 PRODUCT USE COMPLAINT 4
834 PULSE ABSENT 4
835 RASH PAPULAR 4
836 RENAL ARTERY STENOSIS 4
837 RENAL PAPILLARY NECROSIS 4
838 RESPIRATORY ACIDOSIS 4
839 RESPIRATORY SYNCYTIAL VIRUS INFECTION 4
840 RESPIRATORY TRACT INFECTION 4
841 RHEUMATOID ARTHRITIS 4
842 RIGHT VENTRICULAR DYSFUNCTION 4
843 SELF-MEDICATION 4
844 SKIN LACERATION 4
845 SPONTANEOUS HAEMATOMA 4
846 STEROID DIABETES 4
847 SUICIDAL BEHAVIOUR 4
848 SWELLING OF EYELID 4
849 TACHYPNOEA 4
850 THYROID DISORDER 4
851 TORSADE DE POINTES 4
852 TRANSIENT ISCHAEMIC ATTACK 4
853 TRAUMATIC INTRACRANIAL HAEMORRHAGE 4
854 TRYPTASE INCREASED 4
855 TUBULOINTERSTITIAL NEPHRITIS 4
856 TYPE I HYPERSENSITIVITY 4
857 URINARY HESITATION 4
858 URINE GLUCOSE/CREATININE RATIO INCREASED 4
859 URINE OUTPUT DECREASED 4
860 VENTRICULAR ARRHYTHMIA 4
861 VITAMIN D DEFICIENCY 4
862 WRONG DRUG ADMINISTERED 4
863 ABDOMINAL COMPARTMENT SYNDROME 3
864 ABDOMINAL INFECTION 3
865 ABNORMAL FAECES 3
866 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 3
867 ACUTE HEPATIC FAILURE 3
868 ACUTE MYELOID LEUKAEMIA 3
869 ACUTE MYOCARDIAL INFARCTION 3
870 ACUTE PULMONARY OEDEMA 3
871 ADMINISTRATION SITE PAIN 3
872 ADMINISTRATION SITE WOUND 3
873 ADRENAL INSUFFICIENCY 3
874 AFFECT LABILITY 3
875 AFFECTIVE DISORDER 3
876 ANAEMIA FOLATE DEFICIENCY 3
877 ANAESTHETIC COMPLICATION NEUROLOGICAL 3
878 ANAL HYPOAESTHESIA 3
879 ANAPHYLACTOID SHOCK 3
880 ASTHMA 3
881 ATAXIA 3
882 ATELECTASIS 3
883 ATRIOVENTRICULAR BLOCK COMPLETE 3
884 AUTOIMMUNE DISORDER 3
885 BILE DUCT STENOSIS 3
886 BILIARY COLIC 3
887 BILIARY SEPSIS 3
888 BLADDER NECROSIS 3
889 BLADDER PAIN 3
890 BLADDER ULCER 3
891 BLOOD LOSS ANAEMIA 3
892 BLOOD PHOSPHORUS DECREASED 3
893 BLOOD PRESSURE SYSTOLIC INCREASED 3
894 BONE MARROW TRANSPLANT 3
895 CARBOHYDRATE ANTIGEN 125 INCREASED 3
896 CARBON DIOXIDE INCREASED 3
897 CARDIAC TAMPONADE 3
898 CATHETER SITE DISCOLOURATION 3
899 CATHETER SITE PRURITUS 3
900 CEREBRAL DISORDER 3
901 CERVIX CARCINOMA 3
902 CHEMICAL SUBMISSION 3
903 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 3
904 COLITIS 3
905 COMPARTMENT SYNDROME 3
906 CONJUNCTIVITIS 3
907 CONTRAINDICATED PRODUCT ADMINISTERED 3
908 CYTOMEGALOVIRUS INFECTION 3
909 DEAFNESS UNILATERAL 3
910 DEVICE ALLERGY 3
911 DEVICE COLOUR ISSUE 3
912 DIABETIC FOOT 3
913 DISCOLOURED VOMIT 3
914 DIZZINESS EXERTIONAL 3
915 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 3
916 DRUG DIVERSION 3
917 DRUG LEVEL INCREASED 3
918 EAR CONGESTION 3
919 EAR DISCOMFORT 3
920 EARLY SATIETY 3
921 EMOTIONAL DISTRESS 3
922 ENDOCARDITIS 3
923 ERYTHEMA MULTIFORME 3
924 ESSENTIAL HYPERTENSION 3
925 EYE MOVEMENT DISORDER 3
926 EYE PRURITUS 3
927 FAECALOMA 3
928 FEELING OF BODY TEMPERATURE CHANGE 3
929 FIBROSIS 3
930 FREQUENT BOWEL MOVEMENTS 3
931 FRUSTRATION TOLERANCE DECREASED 3
932 FULL BLOOD COUNT ABNORMAL 3
933 GLYCOSYLATED HAEMOGLOBIN INCREASED 3
934 HAEMATOCRIT DECREASED 3
935 HAEMODIALYSIS 3
936 HEPATITIS ACUTE 3
937 HEPATOBILIARY DISEASE 3
938 HOMICIDAL IDEATION 3
939 HOMICIDE 3
940 HUMAN HERPESVIRUS 6 INFECTION 3
941 HYPERAEMIA 3
942 HYPERCALCAEMIA 3
943 HYPERVENTILATION 3
944 HYPOGAMMAGLOBULINAEMIA 3
945 HYPOGLYCAEMIA NEONATAL 3
946 HYPOKINESIA 3
947 HYPOTHYROIDISM 3
948 HYPOVOLAEMIC SHOCK 3
949 IGA NEPHROPATHY 3
950 ILL-DEFINED DISORDER 3
951 IMMUNE THROMBOCYTOPENIC PURPURA 3
952 IMMUNODEFICIENCY 3
953 IMPAIRED HEALING 3
954 INCORRECT DOSE ADMINISTERED BY DEVICE 3
955 INFUSION SITE EXFOLIATION 3
956 INFUSION SITE HYPOAESTHESIA 3
957 INFUSION SITE LACERATION 3
958 INJECTION SITE THROMBOSIS 3
959 INTENTIONAL DRUG MISUSE 3
960 INTESTINAL INFARCTION 3
961 IRON DEFICIENCY ANAEMIA 3
962 KIDNEY FIBROSIS 3
963 LIGAMENT SPRAIN 3
964 LOWER RESPIRATORY TRACT INFECTION 3
965 LYMPHOEDEMA 3
966 MEDICAL DEVICE SITE ERYTHEMA 3
967 MENINGITIS 3
968 MENTAL DISORDER 3
969 METABOLIC DISORDER 3
970 MOOD ALTERED 3
971 MOTOR DYSFUNCTION 3
972 MULTIPLE SCLEROSIS 3
973 MUSCULOSKELETAL PAIN 3
974 MYOCARDIAL FIBROSIS 3
975 MYOSITIS 3
976 NECROSIS 3
977 NEPHROGENIC DIABETES INSIPIDUS 3
978 NERVE COMPRESSION 3
979 NERVE INJURY 3
980 NEUROGENIC BOWEL 3
981 NO ADVERSE EVENT 3
982 NO THERAPEUTIC RESPONSE 3
983 OLIGURIA 3
984 ORTHOSTATIC HYPOTENSION 3
985 PARADOXICAL DRUG REACTION 3
986 PAROSMIA 3
987 PATIENT DISSATISFACTION WITH TREATMENT 3
988 PELVIC PAIN 3
989 PERICARDITIS 3
990 PERIORBITAL SWELLING 3
991 PERIPHERAL COLDNESS 3
992 PERIPHERAL MOTOR NEUROPATHY 3
993 PERIPHERAL SENSORY NEUROPATHY 3
994 PERITONITIS 3
995 PETECHIAE 3
996 PNEUMATOSIS INTESTINALIS 3
997 PNEUMOMEDIASTINUM 3
998 PRIMARY BILIARY CHOLANGITIS 3
999 PROCALCITONIN INCREASED 3